Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-004774
Filing Date
2025-04-14
Accepted
2025-04-14 17:15:35
Documents
62
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20250228x10q.htm   iXBRL 10-Q 1867403
2 EX-10.1 cydy-20250228xex10d1.htm EX-10.1 100567
3 EX-10.2 cydy-20250228xex10d2.htm EX-10.2 58401
4 EX-31.1 cydy-20250228xex31d1.htm EX-31.1 9185
5 EX-31.2 cydy-20250228xex31d2.htm EX-31.2 9330
6 EX-32 cydy-20250228xex32.htm EX-32 7650
  Complete submission text file 0001558370-25-004774.txt   6818102

Data Files

Seq Description Document Type Size
7 EX-101.SCH cydy-20250228.xsd EX-101.SCH 52996
8 EX-101.CAL cydy-20250228_cal.xml EX-101.CAL 47734
9 EX-101.DEF cydy-20250228_def.xml EX-101.DEF 171100
10 EX-101.LAB cydy-20250228_lab.xml EX-101.LAB 361961
11 EX-101.PRE cydy-20250228_pre.xml EX-101.PRE 293030
65 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20250228x10q_htm.xml XML 1066471
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 25836767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)